From: 13/07/2017 to: 18/07/2017 ESMO-ESO Course on Medical Oncology for Medical Students, Valencia, Spain                                        From: 15/07/2017 to: 15/07/2017 Breast Cancer in Young Women: Joint DFCI-ESO Symposium, Boston, US                                        From: 28/08/2017 to: 08/09/2017 ESO-ESSO-ESTRO Multidisciplinary Course in Oncology for Medical Students, Antwerp, Belgium                                        From: 06/10/2017 to: 07/10/2017 Eastern Europe and Balkan Region Refresher Course on Breast Cancer, Krakow, Poland                                        From: 18/10/2017 to: 20/10/2017 4th Masterclass in Clinical Oncology, Tbilisi, Georgia                                        From: 18/10/2017 to: 18/10/2017 ESO Breast Cancer Observatory, Tehran, Iran                                        From: 27/10/2017 to: 28/10/2017 9th Clinical Oncology Update - Onkologia 2017, Krakow, Poland                                        From: 02/11/2017 to: 04/11/2017 ESO-ESMO Advanced Breast Cancer Fourth International Consensus Conference (ABC4), Lisbon, Portugal                                        From: 02/12/2017 to: 04/12/2017 ESO-ESMO-RCE Clinical Update on Rare Adult Solid Cancers, Milan, Italy                                        From: 15/12/2017 to: 18/12/2017 6th Arab and Southern European Countries Masterclass in Clinical Oncology, Limassol, Cyprus                                        From: 24/03/2018 to: 29/03/2018 17th ESO-ESMO Masterclass in Clinical Oncology, Nauen OT Groß Behnitz (Berlin area), Germany                                        From: 18/04/2018 to: 22/04/2018 4th ESO-ESMO Latin-American Masterclass in Clinical Oncology, Mexico City, Mexico                                        From: 6/10/2018 to: 8/10/2018 4th ESO-ESMO Breast Cancer in Young Women International Conference, Lugano, Switzerland



Diagnosing and managing cachexia in cancer patients needs an independent review with the aim of establishing the level of evidence available for possible recommendations for oncological clinical practice with special regard to the identification of this condition at the early stage of its development.

Formed in 2012, the objectives of this task force are to raise awareness in the area of nutrition/cachexia in medical oncology and to come out with a common message for the definition of cachexia as well as a classification and staging system.

Progress to Date:

Production of a position paper, Early recognition of malnutrition and cachexia in the cancer patient: a position paper of a European School of Oncology Task Force, has been published in Annals of Oncology online on 25 February 2014 and in print in the August 2014 issue.

Future plans: 

The Task Force aims to

• organise conferences on this topic
  Last Conference: Cachexia and Nutrition in Advanced Cancer Patients: A Multidisciplinary Approach
  13-14 March 2015, Barcelona, Spain

• develop guidelines

The Task Force is chaired by Matti Aapro (CH).
Members of the expert group are: Jann Arends (DE), Federico Bozzetti (IT), Ken Fearon (UK), Jorn Herrstedt (DK), Jane Hopkinson (UK), Jean-Claude Horiot (CH), Aminah Jatoi (USA), Nathalie Jacquelin-Ravel (CH), Stein Kaasa (NO), Florian Strasser (CH).

For further information, please contact:
Alexandra Zampetti

Helsinn Healthcare, a sustaining member of the Sharing Progress in Cancer Care (SPCC) programme, has provided an unrestricted grant towards ESO for this initiative. SPCC is a pioneering partnership between the European School of Oncology (ESO) and some of the world’s leading pharmaceutical companies.